載入...
Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses
We recently demonstrated that dual therapy combining AURKA and MDM2 antagonists is effective against melanoma in preclinical settings. Notably, besides inducing apoptosis, this regimen led to tumor senescence and stimulated the host's antitumor immune defenses. Treatments leveraging both cancer...
Na minha lista:
| 發表在: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570092/ https://ncbi.nlm.nih.gov/pubmed/26405565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1009299 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|